Skip to main content
    S

    Stereotaxis Inc (STXS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $0.90
    +0.09 (+11.57%)

    Market Cap: $80.94M

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Stereotaxis Inc (STXS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Stereotaxis (STXS) has a market cap of $80.94M and an enterprise value of $84.28M. It kept -70.86% of revenue as net income over the last 12 months. Its share count is up 11.45% from a year earlier.

    Total Valuation

    Enterprise value is 4.14% above the market cap, as debt exceeds cash.

    Market Cap$80.94M
    Enterprise Value$84.28M
    Latest price (Nov 17, 2026)$0.90

    Key Dates

    The next earnings report is expected on Mar 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 8, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.52% in the quarter ended Sep 30, 2026 and grew 9.31% a year over 2 years.

    Shares Outstanding102.55M
    Shares Change (YoY)+11.45%
    Shares Change (QoQ)+2.52%
    Share Count Growth (2Y CAGR)+9.31%

    Valuation Ratios

    Sales and book value multiples are 2.9x and 4.3x. Its year-end P/S ranged from 0.4x to 110.5x from 2016 to 2025.

    P/S Ratio2.9x
    Forward P/S2.6x
    P/B Ratio4.3x

    Valuation history and multiples

    Price Statistics

    The stock is down 59.66% over 52 weeks and trades 18.92% below its 50-day average.

    Beta (1Y)1.19
    52-Week Change-59.66%
    1-Month Change-11.33%
    3-Month Change-35.10%
    6-Month Change-48.23%
    5-Year Change-85.38%
    10-Year Change+23.23%
    Total Return (1Y)-59.66%
    Total Return (3Y CAGR)-16.88%
    Total Return (5Y CAGR)-32.77%
    Max Drawdown (1Y)-71.23%
    Max Drawdown (3Y)-77.52%
    Sharpe Ratio (1Y)-1.71
    Correlation with SPY (1Y)0.30
    50-Day Average$1.11
    200-Day Average$1.61
    52-Week Range$0.80 to $2.86
    RSI (14 Days)42.7
    Average Volume (20 Days)991.25K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.08x current liabilities, and total debt is 0.34x shareholder equity.

    Current Ratio1.08x
    Quick Ratio0.67x
    Debt / Equity0.34x
    Interest Coverage75.82x

    Returns and Efficiency

    Return on invested capital is -62.43% over the last 12 months, against a 5-year average of -95.06%.

    Return on Equity (ROE)-104.60%
    Return on Assets (ROA)-27.21%
    Return on Invested Capital (ROIC)-62.43%
    ROA (5Y Average)-38.82%
    ROIC (5Y Average)-95.06%
    Asset Turnover0.49x
    Inventory Turnover1.16x
    Receivables Turnover4.80x
    Cash Conversion Cycle213 days

    Scores

    STXS has an Altman Z-Score of -9.73, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-9.73
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $31.53M over the last 12 months is up 4.84% from the 12 months before.

    Revenue$31.53M
    Revenue Growth (YoY)+4.84%
    Gross Profit$16.56M
    Operating Income-$22.67M
    Pretax Income-$22.34M
    Net Income-$22.34M
    EBITDA-$20.97M
    Reported EPS (TTM)-$0.24

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 26.01% of the $82.11M in total assets.

    Cash and Equivalents$3.98M
    Total Debt$7.32M
    Net Debt$3.35M
    Net Debt Per Share$0.03
    Working Capital$2.68M
    Shareholder Equity$21.36M
    Book Value Per Share$0.21
    Tangible Book Value-$14.90M
    Total Assets$82.11M
    Total Liabilities$55.58M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $240.00K of capital spending, operating cash flow left -$15.50M of free cash flow.

    Operating Cash Flow-$15.26M
    Capital Expenditures$240.00K
    Free Cash Flow-$15.50M
    FCF Per Share-$0.15
    Depreciation and Amortization$1.70M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -71.90%, against a 5-year average of -69.06%.

    Gross Margin52.53%
    Operating Margin-71.90%
    Pretax Margin-70.84%
    Net Margin-70.86%
    EBITDA Margin-66.51%
    FCF Margin-49.17%
    Gross Margin (5Y Average)58.88%
    Operating Margin (5Y Average)-69.06%
    Net Margin (5Y Average)-65.83%

    Growth

    Revenue grew 4.78% a year over 3 years.

    Revenue Growth (3Y CAGR)+4.78%
    Revenue Growth (5Y CAGR)+3.99%
    Book Value Per Share Growth (2Y CAGR)-15.69%
    Tangible Book Per Share Growth (2Y CAGR)-58.36%

    Revenue and profit by year

    Dividends and Yields

    STXS does not pay a dividend. Its free cash flow yield is -16.88%.

    FCF Yield-16.88%
    Buyback Yield-15.34%
    Shareholder Yield-15.34%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jul 11, 2012.

    Last Split DateJul 11, 2012
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 11 similar companies, STXS has the 5th highest P/S.

    P/S Ratio2.9x vs 2.6x median
    ROIC-62.43% vs 6.74% median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.84% vs +9.82% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 11.43% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+11.43%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About STXS

    What is STXS's market cap?

    Stereotaxis has a market cap of $80.94M. Its enterprise value, which adds debt and subtracts cash, is $84.28M.

    How many shares of STXS are outstanding?

    Stereotaxis has 102.55M shares outstanding. The count is up 11.45% from a year earlier.

    Does STXS pay a dividend?

    No. Stereotaxis does not pay a dividend.

    How much debt does STXS have?

    Stereotaxis has $7.32M of total debt and $3.98M of cash and equivalents, a net debt position of $3.35M.